Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients
Open Access
- 21 March 2013
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 121 (12) , 2347-2351
Abstract
Key Points: A small-molecule peptide inhibitor of VIP-signaling protected murine allo-BMT recipients from lethal mCMV infection without increasing GvHD. Treatment with the VIP inhibitor reduced viral loads, increased antigen-specific T-cells, and decreased PD-1 expression.Keywords
This publication has 27 references indexed in Scilit:
- IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activityBlood, 2012
- Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells Enhances Th1 Polarization and Antiviral Immunity in MiceThe Journal of Immunology, 2011
- Role of PD-1 in regulating acute infectionsCurrent Opinion in Immunology, 2010
- Activation, Immune Polarization, and Graft-versus-Leukemia Activity of Donor T Cells Are Regulated by Specific Subsets of Donor Bone Marrow Antigen-Presenting Cells in Allogeneic Hemopoietic Stem Cell TransplantationThe Journal of Immunology, 2009
- The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responsesCurrent Opinion in Immunology, 2009
- Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppressionJournal of Experimental Medicine, 2007
- Chronic GvHD decreases antiviral immune responses in allogeneic BMTBlood, 2007
- Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cellsBlood, 2006
- A VIP hybrid antagonist: From developmental neurobiology to clinical applicationsCellular and Molecular Neurobiology, 1995
- VIP Gene Expression in Rat Thymus and SpleenBrain, Behavior, and Immunity, 1993